MedPlus Health Services Limited has informed the stock exchanges that Optival Health Solutions Private Limited, its subsidiary, has received 2 suspension orders relating to drug licences for retail stores located in Karnataka.
The actions were issued by officials of the Drugs Control Administration and are expected to have a limited financial impact on the business.
One of the suspension orders was issued by the Assistant Director, Drugs Control Administration, Madikeri Circle, Karnataka.
The order relates to a MedPlus store located on Kohinoor Road, Madikeri, where the drug licence has been suspended for a period of two days. The company stated that the order was received on May 22, 2026.
The 2nd order was issued by the Assistant Director, Drugs Control Administration, Bangalore Circle-4. Under this order, the drug licence of a store situated at Nagarabhavi 2nd Stage, Karnataka, has been suspended for three days.
According to the company’s disclosure, the suspension orders were issued under Rule 65 of the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945.
The filing did not provide further details regarding the specific nature of the alleged violations.
The company disclosed the development under Regulation 30 of the SEBI Listing Regulations as a material event requiring notification to investors.
MedPlus estimated a potential revenue loss of ₹0.54 lakh from the suspension of the Madikeri store licence. The Nagarabhavi 2nd Stage store could face a potential revenue loss of ₹1.98 lakh during the suspension period.
Based on the company’s estimates, the combined potential revenue impact from both actions stands at approximately ₹2.52 lakh. The disclosure did not indicate any broader operational impact on the company’s retail network.
Read More: MedPlus Health Share Price Jumps 11% After Q4 FY26 Net Profit Rises 25% and Revenue Grows 24%!
As of 25 May 2026, at 9:31 AM, MedPlus Health Services share price is trading at ₹886.70 per share, reflecting a decline of 1.46% from its previous closing price.
MedPlus Health Services’ subsidiary has received temporary drug licence suspension orders for two stores in Karnataka. While the actions may result in an estimated revenue impact of ₹2.52 lakh, the suspensions are limited in duration and relate to individual retail outlets.
Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: May 25, 2026, 9:35 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
